Skip to main content

Advertisement

Log in

Rheumatology in Egypt: back to the future

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Medical knowledge in ancient Egypt had a remarkable reputation since rulers of other empires used to request the pharaoh to send them their best physician to treat their beloved ones. Many rheumatologic conditions as giant-cell arteritis, reactive arthritis and other forms of spondyloarthritis have been identified in ancient Egyptian materials. Rheumatologists in Egypt are enormously expanding and mastering the tools that aid them in enhancing the management of rheumatic diseases. More Egyptian rheumatologists are actively participating in the annual European League Against Rheumatism (EULAR) and American College of Rheumatology conferences and those attached to well known state of the art centers are increasing. EULAR certified Egyptian MSUS trainers are effectively performing regionally. This review throws light on the rheumatology practice in Egypt, its progress from ancient times passing through Egyptian medical healthcare services, education systems for rheumatologists, rheumatology associations, an overview on the spectrum of rheumatic diseases through publications in the field till future perspectives. Rheumatology in Egypt is an actively growing and dynamic specialty of medicine with considerable contributions to the world’s literature. These days, persistent efforts are mandatory to raise the standard of clinical and basic research, to optimize clinical practice with regard to new biologics, to develop tailored and targeted therapies for the rheumatic diseases, and to meet the medical demands of the exponentially increasing Egyptian population. Opportunities and challenges discussed high-lighten future perspectives needed to boost the rheumatology practice in Egypt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kwiecinski J, Rothschild BM (2016) No rheumatoid arthritis in ancient Egypt: a reappraisal. Rheumatol Int 36:891–895

    Article  PubMed  Google Scholar 

  2. Feldtkeller E, Lemmel EM, Russell AS (2003) Ankylosing spondylitis in the pharaohs on ancient Egypt. Rheumatol Int 23:1–5

    Article  PubMed  Google Scholar 

  3. Saleem SN, Hawass Z (2014) Ankylosing spondylitis or diffuse idiopathic skeletal hyperostosis (DISH) in Royal Egyptian mummies of 18th–20th dynasties? CT and archaeology studies. Arthritis Rheumatol. https://doi.org/10.1002/art.38864

    Article  PubMed  Google Scholar 

  4. Deshpande S (2014) History of rheumatology. Med J DY Patil Univ 7:119–123

    Article  Google Scholar 

  5. Braunstein EM, White SJ, Russell W, Harris JE (1988) Paleoradiologic evaluation of the Egyptian royal mummies. Skelet Radiol 17:348–352

    Article  CAS  Google Scholar 

  6. Li Z, Yang Y (2012) Rheumatology in China: challenges and development—developing as a rapidly growing specialty. Rheumatology 51:1733–1734

    Article  PubMed  Google Scholar 

  7. Misra DP. Sharma A, Agarwal V (2018) Rheumatology science and practice in India. Rheumatol Int 38:1587–1600

    Article  PubMed  Google Scholar 

  8. Adebajo A, Espinoza LR (2018) Rheumatology in and from Slovenia. Clin Rheumatol. https://doi.org/10.1007/s10067-018-4307-8

    Article  PubMed  Google Scholar 

  9. Abhishek A, Iagnocco A, Bijlsma JWJ, Doherty M, Lioté F (2018) Cross-sectional survey of the undergraduate rheumatology curriculum in European medical schools: a EULAR School of Rheumatology initiative. RMD Open 4(2):e000743

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gibson T (2015) Rheumatology in India and Pakistan today: the journey continues. Rheumatology 54:753–754

    Article  CAS  PubMed  Google Scholar 

  11. Misra DP, Agarwal V, Negi VS (2016) Rheumatology in India: a bird’s eye view on organization, epidemiology, training programs and publications. J Korean Med Sci 31:1013–1019

    Article  PubMed  PubMed Central  Google Scholar 

  12. Davatchi F (2009) Rheumatology in Iran. Int J Rheum Dis 12:283–287

    Article  PubMed  Google Scholar 

  13. Kim HY, Song YW (2016) The dynamic evolution of rheumatology in Korea. Nat Rev Rheumatol 12:183–189

    Article  PubMed  Google Scholar 

  14. Chipeta J, Njobvu P, McGill PE et al (2014) Progress made towards enhancement of rheumatology education and practice in Zambia: review of an ILAR-supported project. Clin Rheumatol 33:1367–1372

    Article  PubMed  PubMed Central  Google Scholar 

  15. Snaith ML, Steven M (2011) Rheumatology practice in Britain: 50 years in evolution, as seen through the eyes of the journal-developments in British rheumatology. Rheumatology 50:1001–1003

    Article  PubMed  Google Scholar 

  16. Gasparyan AY, Ayvazyan L, Blackmore H et al (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417

    Article  PubMed  Google Scholar 

  17. Albert I, Mansoor A, Helal K et al (2017) The 7th report on the healthcare sector in Egypt. Colliers Int Healthc Serv Middle East N Afr 7:1–18

    Google Scholar 

  18. Regional Health Systems Observatory-EMRO (2006) Health Systems Profile—Egypt. Health System Organization, Cairo, pp 17–21

    Google Scholar 

  19. Elgharably A, Gomaa AI, Crossey MM et al (2016) Hepatitis C in Egypt—past, present, and future. Int J Gen Med 10:1–6

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ayoub MM (2017) Medical tourism in Egypt: opportunities and challenges. Thesis submitted in partial fulfillment of the Master degree of Public Administration, The American University in Cairo. Shahjahan B (Supervisor), Digital Archive and Research (DAR) Repository, pp 1–83

  21. Kroop SF, Chung CP, Davidson MA et al (2016) Rheumatologic skills development: what are the needs of internal medicine residents? Clin Rheumatol 35:2109–2115

    Article  PubMed  Google Scholar 

  22. Pincus T, Gibofsky A, Weinblatt ME (2002) Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum 46:851–854

    Article  PubMed  Google Scholar 

  23. McNearney TA, Hunnicutt SE, Maganti R et al (2008) What factors relate to job satisfaction among rheumatologists? J Clin Rheumatol 14:133–137

    Article  PubMed  Google Scholar 

  24. Barber CE, Jewett L, Badley EM et al (2017) Stand up and be counted: measuring and mapping the rheumatology workforce in Canada. J Rheumatol 44:248–257

    Article  PubMed  Google Scholar 

  25. FitzGerald JD, Battistone M, Brown CR Jr et al (2013) American College of Rheumatology Committee on rheumatology training and workforce issues. Regional distribution of adult rheumatologists. Arthritis Rheum 65:3017–3025

    Article  PubMed  Google Scholar 

  26. Smith BJ, Bolster MB, Slusher B et al (2018) Core curriculum to facilitate the expansion of a rheumatology practice to include nurse practitioners and physician assistants. Arthritis Care Res 70:672–678

    Article  Google Scholar 

  27. Kessler EA, Sherman AK, Becker ML (2016) Decreasing patient cost and travel time through pediatric rheumatology telemedicine visits. Pediatr Rheumatol Online J 14:54

    Article  PubMed  PubMed Central  Google Scholar 

  28. Abd El Monaem SM, Hashaad NI, Ibrahim NH (2017) Correlations between ultrasonographic findings, clinical scores, and depression in patients with knee osteoarthritis. Eur J Rheumatol 4:205–209

    Article  PubMed  PubMed Central  Google Scholar 

  29. Mortada M, Zeid A, Al-Toukhy MA et al (2016) Reliability of a proposed ultrasonographic grading scale for severity of primary knee osteoarthritis. Clin Med Insights Arthritis Musculoskelet Disord 9:161–166

    Article  PubMed  PubMed Central  Google Scholar 

  30. Hammad YH, Magid HR, Sobhy MM (2015) Clinical and biochemical study of the comparative efficacy of topical versus oral glucosamine/chondroitin sulfate on osteoarthritis of the knee. Egypt Rheumatol 37:85–91

    Article  Google Scholar 

  31. Khalifa N, El-Husseini T, Morrah A et al (2014) Use of ibuprofen sustained release for treating osteoarthritic pain: findings from 15 general medical practices in Egypt. Open Access Rheumatol 6:49–56

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. El-Sherbiny NA, Younis A, Masoud M (2016) A comprehensive assessment of the physical, nutritional, and psychological health status of the elderly populace in the Fayoum Governorate (Egypt). Arch Gerontol Geriatr 66:119–26

    Article  PubMed  Google Scholar 

  33. El Miedany Y, El Gaafary M, Palmer D et al (2012) Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: a pilot study. Rheumatol Int 32:3061–3068

    Article  CAS  PubMed  Google Scholar 

  34. Sakr BR, Elfishawi MM, ElArousy MH et al (2018) Rheumatoid arthritis: a single-center Egyptian experience. Immunol Investig 47:293–302

    Article  CAS  Google Scholar 

  35. Abd Elazeem MI, Salem MN (2018) Can rheumatoid arthritis affect sleep in Egyptian patients? Egypt Rheumatol 40:11–16

    Article  Google Scholar 

  36. Mostafa H, Radwan A (2013) The relationship between disease activity and depression in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol 35:193–199

    Article  Google Scholar 

  37. El-Mansoury TM, Taal E, Abdel-Nasser AM et al (2008) Loneliness among women with rheumatoid arthritis: a cross-cultural study in The Netherlands and Egypt. Clin Rheumatol 27:1109–1118

    Article  PubMed  Google Scholar 

  38. Ismail F, Ali HA, Ibrahim HM (2011) Possible role of leptin, and tumor necrosis factor-alpha in hypoandrogenicity in patients with early rheumatoid arthritis. Egypt Rheumatol 33:209–215

    Article  CAS  Google Scholar 

  39. Arayssi T, Harfouche M, Darzi A et al (2018) Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines. Clin Rheumatol 37(11):2961–2962

    Article  PubMed  Google Scholar 

  40. Hegab M, Abdelwahab AF, Yousef A et al (2016) CD28 and PTPN22 are associated with susceptibility to rheumatoid arthritis in Egyptians. Hum Immunol 77:522–526

    Article  CAS  PubMed  Google Scholar 

  41. Abdelsalam A, Tharwat S, Abo Almauty M et al (2017) Demographic, clinical and radiological characteristics of seronegative spondyloarthritis Egyptian patients: a rheumatology clinic experience in Mansoura. Egypt Rheumatol 39:109–114

    Article  Google Scholar 

  42. Ito S, Gross WL, Reinhold-Keller E et al (2006) Rheumatology in Japan, Germany, and Egypt: a comparison of medical practices. Acta Med Biol 54:51–58

    Google Scholar 

  43. Ibrahim SE, Helmi A, Yousef TM et al (2012) Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis. Egypt Rheumatol 34:83–89

    Article  CAS  Google Scholar 

  44. Emad Y, Ragab Y, Gheita T et al (2012) Knee enthesitis and synovitis on magnetic resonance imaging in patients with psoriasis without arthritic symptoms. J Rheumatol 39:1979–1986

    Article  PubMed  Google Scholar 

  45. Emad Y, Ragab Y, Shaarawy A et al (2009) Can magnetic resonance imaging differentiate undifferentiated arthritis based on knee imaging? J Rheumatol 36:1963–1970

    Article  PubMed  Google Scholar 

  46. El-Hadidi KT (1998) Systemic lupus erythematosus in Egypt: clinical and serological features in 521 patients. Egypt Rheumatol 20:215–229

    Google Scholar 

  47. El-Garf AK, Gheith RE, Badran SN (2017) Clinical pattern in Egyptian systemic lupus erythematosus patients with pleuropulmonary involvement. Egypt Rheumatol 39:83–88

    Article  Google Scholar 

  48. Gamal SM, Fawzy SM, Abdo M et al (2017) Immunological profile and dyslipidemia in Egyptian Systemic Lupus Erythematosus patients. Egypt Rheumatol 39:89–92

    Article  Google Scholar 

  49. Hussein DA, El Bakry SA, Morshedy NA et al (2018) Ocular manifestations in Egyptian systemic lupus erythematosus patients and their relation with disease activity and anti-phospholipid antibodies. Egypt Rheumatol 40:179–182

    Article  Google Scholar 

  50. Gaballah NM, El-Najjar AR (2018) Clinical characteristics and health related quality of life (HRQoL) in Egyptian patients with systemic lupus erythematosus. Egypt Rheumatol. https://doi.org/10.1016/j.ejr.2018.07.003

    Article  Google Scholar 

  51. Abdul-Sattar AB, Abou El Magd SA (2015) Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate. Rheumatol Int 35:1045–1051

    Article  CAS  PubMed  Google Scholar 

  52. Gheita TA, Gamal SM, El-Kattan E (2011) Uterine-umbilical artery Doppler velocimetry and pregnancy outcome in SLE patients: relation to disease manifestations and activity. Egypt Rheumatol 33:187–193

    Article  Google Scholar 

  53. Ghaleb RM, Omar GM, Ibrahim MA (2011) Avascular necrosis of bone in systemic lupus erythematosus. Egypt Rheumatol 33:27–33

    Article  Google Scholar 

  54. Momtaz OM, Senara SH, Zaky SH et al (2018) Critically ill systemic lupus erythematosus patients referred to the intensive care unit of Fayoum University Hospital: frequency, complications and outcome. Egypt Rheumatol. https://doi.org/10.1016/j.ejr.2018.05.003

    Article  Google Scholar 

  55. Elsayed AM, Elhefny AM, Abogabal MM et al (2018) Progressive systemic sclerosis in Egyptian patients: clinical characteristics and nail fold capillaroscopy. Egypt Rheumatol. https://doi.org/10.1016/j.ejr.2018.01.009

    Article  Google Scholar 

  56. Ismail F, Abdel-Azeem MI, Abd El-Haleem H et al (2013) Feto-maternal outcome in patients with systemic sclerosis. Egypt Rheumatol 35:101–106

    Article  Google Scholar 

  57. El-Tallawy HN, Khedr EM, Qayed MH et al (2005) Epidemiological study of muscular disorders in Assiut, Egypt. Neuroepidemiology 25:205–211

    Article  PubMed  Google Scholar 

  58. Gheita TA, Hammam N (2018) Epidemiology and awareness of osteoporosis: a viewpoint from the Middle East and North Africa. Int J Clin Rheumatol 13:134–147

    Article  Google Scholar 

  59. Taha M (2011) Prevalence of osteoporosis in Middle East systemic literature review. In: 10th Egyptian congress of osteoporosis and osteoarthritis (ECOO), April 2011. http://www.scribd.com/doc/53103901/Osteopoorosis-Cairo-April-2011-v1

  60. El-Tawab SS, Saba EK, Elweshahi HM et al (2016) Knowledge of osteoporosis among women in Alexandria (Egypt): a community based survey. Egypt Rheumatol 38:225–231

    Article  Google Scholar 

  61. El-Husseini T, Adawy AH, Bassiouni HM et al (2016) Registry on the management of postmenopausal and corticosteroid-induced osteoporosis in Egypt. Egypt Orthop J 51:215–222

    Article  Google Scholar 

  62. Quartuccio L, Isola M, Corazza L et al (2014) Validation of the classification criteria for cryoglobulinaemic vasculitis. Rheumatology 53:2209–2213

    Article  PubMed  Google Scholar 

  63. Shahin AA, Zayed HS, Elrefai RM et al (2018) The distribution and outcome of vasculitic syndromes among Egyptians: a multi-centre study including 630 patients. Egypt Rheumatol 40(4):243–248

    Article  Google Scholar 

  64. Shahin AA, Shaker OG, Darweesh HE et al (2016) Does human leukocyte antigen influence the risk of development and type of vasculitis in Egyptian patients with chronic hepatitis C virus infection? Egypt Rheumatol 38:307–312

    Article  Google Scholar 

  65. Gheita TA, Samad HM, Mahdy MA et al (2014) Pattern of primary vasculitis with peripheral ischemic manifestations: report of a case series and role of vascular surgery. Curr Rheumatol Rev 10:126–130

    Article  PubMed  Google Scholar 

  66. Gheita TA, Abd El-Latif E, Egyptian College of Rheumatology Behcet’s disease study group (ECR-BDSG) et al (2018) AB1348 prevalence, gender-predominance and clinical presentation of Behçet’s disease in Egypt: preliminary findings from a multicenter nationwide study. Ann Rheum Dis 77:1762–1763

    Google Scholar 

  67. El Menyawi MM, Raslan HM, Edrees A (2009) Clinical features of Behcet’s disease in Egypt. Rheumatol Int 29:641–646

    Article  PubMed  Google Scholar 

  68. Hussein MA, Ellawindi MI, Ragab G (2017) Performance of classification criteria for Behcet’s disease in an Egyptian cohort. Indian J Rheumatol 12:152–155

    Article  Google Scholar 

  69. Ragab G, Elshahaly M, Bardin T (2017) Gout: an old disease in new perspective–a review. J Adv Res 8(5):495–511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649–662

    Article  PubMed  Google Scholar 

  71. Gheita TA, El-Fishawy HS, Nasrallah MM et al (2012) Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions. Int J Rheum Dis 15:521–525

    Article  CAS  PubMed  Google Scholar 

  72. Olaosebikan BH, Adelowo OO, Animashaun BA et al (2017) Spectrum of paediatric rheumatic diseases in Nigeria. Pediatr Rheumatol Online J 15:7

    Article  PubMed  PubMed Central  Google Scholar 

  73. Sorour KA (2014) Rheumatic heart disease in Egypt: gloomy past and promising future. Egypt Heart J 66:139–142

    Article  Google Scholar 

  74. Abou El-Soud AM, El-Najjar A, El-shahawy E et al (2013) Prevalence of juvenile idiopathic arthritis in Sharkia Governorate, Egypt: epidemiological study. Rheumatol Int 33:2315–2322

    Article  PubMed  Google Scholar 

  75. El-Najjar AR, Negm MG, El-Sayed WM et al (2014) The relationship between depression, disease activity and physical function in juvenile idiopathic arthritis patients in Zagazig University Hospitals—Egypt. Egypt Rheumatol 36:145–150

    Article  Google Scholar 

  76. Alkady EA, Rashad SM, Khedr TM et al (2011) Early predictors of increased bone resorption in juvenile idiopathic arthritis: OPG/RANKL ratio, as a key regulator of bone metabolism. Egypt Rheumatol 33:217–223

    Article  CAS  Google Scholar 

  77. Salah S, Lotfy HM, Mokbel AN et al (2011) Damage index in childhood-onset systemic lupus erythematosus in Egypt. Pediatr Rheumatol Online J 9:36

    Article  PubMed  PubMed Central  Google Scholar 

  78. Mohamed DF, Abdel Aziz AB, Hassan SA et al (2018) Juvenile lupus: different clinical and serological presentations compared to adult lupus in Egypt. Egypt Rheumatol 40:55–58

    Article  Google Scholar 

  79. El Miedany Y, El Mikkawy DME, Youssef SS et al (2018) The Egyptian Arabic version of the juvenile arthritis multidimensional assessment report (JAMAR). Rheumatol Int 38:155–161

    Article  PubMed  PubMed Central  Google Scholar 

  80. Brito-Zerón P, Acar-Denizli N, Zeher M, EULAR-SS Task Force Big Data Consortium et al (2017) Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis 76:1042–1050

    Article  PubMed  Google Scholar 

  81. Brito-Zerón P, Acar-Denizli N, Ng WF et al (2018) How immunological profile drives clinical phenotype of primary Sjögren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol 36:102–112

    PubMed  Google Scholar 

  82. El-Rabbat MS, Mahmoud NK, Gheita TA (2017) Clinical significance of fibromyalgia syndrome in different rheumatic diseases: relation to disease activity and quality of life. Reumatol Clin 14(5):285–289

    Article  Google Scholar 

  83. El-Naby MA, Hefny MA, Fahim AE et al (2013) Validation of an adapted arabic version of fibromyalgia syndrome impact questionnaire. Rheumatol Int 33:2561–2567

    Article  PubMed  Google Scholar 

  84. Emad Y, Ragab Y, Zeinhom F et al (2008) Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 35:1371–1377

    CAS  PubMed  Google Scholar 

  85. El-Garf A, Salah S, Iskander I et al (2010) MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations. Rheumatol Int 30:1293–1298

    Article  CAS  PubMed  Google Scholar 

  86. Abdelbaky MS, Mansour HE, Ibrahim SI et al (2011) Prevalence of connective tissue diseases in Egyptian patients presenting with fever of unknown origin. Clin Med Insights Arthritis Musculoskelet Disord 4:33–41

    Article  PubMed  PubMed Central  Google Scholar 

  87. El-Zorkany B, Mokbel A, Gamal SM et al (2016) Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis. Clin Rheumatol 35:1153–1159

    Article  PubMed  Google Scholar 

  88. Mahmoud AA, Sheneef A, Goda AM et al (2016) Association of interferon-γ and its (+ 874 T/A) gene polymorphism with type 2 diabetes mellitus in rheumatoid arthritis patients. Egypt Rheumatol 38:277–282

    Article  Google Scholar 

  89. Gheita TA, Raafat HA, Sayed S et al (2013) Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness. Z Rheumatol 72:172–177

    Article  CAS  PubMed  Google Scholar 

  90. El-saadany H, Abd Elkhalik M, Moustafa T et al (2014) Thyroid dysfunction in systemic lupus erythematosus and rheumatoid arthritis: Its impact as a cardiovascular risk factor. Egypt Rheumatol 36:71–78

    Article  Google Scholar 

  91. El-Hadidi KT, Mansour MA, El-Wakd MM et al (2014) Thyroid dysfunction and anti-thyroid antibodies in Egyptian patients with systemic lupus erythematosus: correlation with clinical musculoskeletal manifestations. Egypt Rheumatol 36:173–178

    Article  Google Scholar 

  92. Gheita TA, Sayed S, Gheita HA et al (2016) Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome. Int J Rheum Dis 19:294–299

    Article  CAS  PubMed  Google Scholar 

  93. Abaza NM, El-Mallah RM, Shaaban A et al (2016) Vitamin D deficiency in Egyptian systemic lupus erythematosus patients: how prevalent and does it impact disease activity? Integr Med Insights 11:27–33

    Article  PubMed  PubMed Central  Google Scholar 

  94. Garf KE, Marzouk H, Farag Y et al (2015) Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus. Rheumatol Int 35:1535–1540

    Article  CAS  PubMed  Google Scholar 

  95. Olama SM, Senna MK, Elarman MM et al (2013) Serum vitamin D level and bone mineral density in premenopausal Egyptian women with fibromyalgia. Rheumatol Int 33:185–192

    Article  CAS  PubMed  Google Scholar 

  96. Abdulazim DO, Salem MM, Hassan M et al (2018) Vitamin D deficiency: an unrecognized cause of flank pain. J Bone Miner Metab 36:605–608

    Article  CAS  PubMed  Google Scholar 

  97. Youssef AA, Shabana A, Senna M et al (2015) AB0332 musculoskeletal manifestations of diabetes mellitus in a cohort of Egyptians. Ann Rheum Dis 74:1004–1005

    Article  Google Scholar 

  98. Mohammed RH, ElMakhzangy HI, Gamal A et al (2010) Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin Rheumatol 29:1373–1380

    Article  PubMed  Google Scholar 

  99. El-Najjar AR, Amar HA, El wahab Selim HA et al (2014) Musculoskeletal disorders in hemodialysis patients and its impact on physical function. Egypt Rheumatol Rehabil 41:152–159

    Article  Google Scholar 

  100. Gheita TA, Ezzat Y, Sayed S et al (2010) Musculoskeletal manifestations in patients with malignant disease. Clin Rheumatol 29:181–188

    Article  PubMed  Google Scholar 

  101. Ismail F, Mahmoud A, Abdelhaleem H et al (2013) Primary Sjögren’s syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia. Rheumatol Int 33:1021–1025

    Article  CAS  PubMed  Google Scholar 

  102. Bardissi W (2016) Bringing biosimilars to Egypt. Healthcare and life science review: Egypt. Pharma Board Room, Cairo, pp 40–41

    Google Scholar 

  103. Li Z-g (2015) A new look at rheumatology in China—opportunities and challenges Nat. Rev Rheumatol 11:313–317

    Google Scholar 

  104. Kiltz U, van der Heijde D, Boonen A et al (2018) Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann Rheum Dis 77(9):1311–1317

    Article  PubMed  Google Scholar 

  105. Filippou G, Scirè CA, Adinolfi A et al (2018) Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints-an international multiobserver study by the OMERACT calcium pyrophosphate deposition disease ultrasound subtask force. Ann Rheum Dis 77:1194–1199

    Article  CAS  PubMed  Google Scholar 

  106. Molto A, Gossec L, Meghnathi B et al (2018) An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis 77:124–127

    Article  PubMed  Google Scholar 

  107. Moltó A, Etcheto A, van der Heijde D et al (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75(6):1016–1023

    Article  CAS  PubMed  Google Scholar 

  108. Maurer B, Distler A, Suliman YA et al (2014) Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Ann Rheum Dis 73:1880–1887

    Article  PubMed  Google Scholar 

  109. Kamel M, Moghazy K, Eid H, Mansour R (2002) Ultrasonographic diagnosis of de Quervain’s tenosynovitis. Ann Rheum Dis 61:1034–1035

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. El Mansoury TM, Hazenberg BP, El Badawy SA et al (2002) Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis 61:42–47

    Article  PubMed  PubMed Central  Google Scholar 

  111. Suarez-Almazor ME, Kim ST, Abdel-Wahab N et al (2017) Review: immune-related adverse events with use of checkpoint inhibitors for immunotherapy of cancer. Arthritis Rheumatol 69:687–699

    Article  PubMed  Google Scholar 

  112. Suliman YA, Dobrota R, Huscher D et al (2015) Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 67:3256–3261

    Article  CAS  PubMed  Google Scholar 

  113. El-Sherif HE, Kamal R, Moawyah O (2018) Hand osteoarthritis and bone mineral density in postmenopausal women; clinical relevance to hand function, pain and disability. Osteoarthr Cartil 16:12–17

    Article  Google Scholar 

  114. GheitaTA El-awar, El-Ansary AH, Raslan MM, El-Defrawy HM AO (2015) Cartilage oligomeric matrix protein (COMP) levels in serum and synovial fluid in osteoarthritis (OA) patients: Correlation with clinical, radiological and laboratory parameters. Osteoarthr Cartil 23(Suppl.2):A85

    Article  Google Scholar 

  115. Mok CC, Soliman S, Ho LY et al (2018) Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis. Arthritis Res Ther 20:6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Hammam N, Rashed A, Abdel-Wahab N (2016) Hand grip strength in juvenile idiopathic arthritis as predictor of disease activity and disability in clinical practice. Rheumatology 55:1709

    Article  PubMed  Google Scholar 

  117. Bassyouni IH, Gheita TA, Talaat RM (2011) Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data. Rheumatology 50:2108–2112

    Article  CAS  PubMed  Google Scholar 

  118. Shah M, Tayar JH, Abdel-Wahab N et al (2018) Myositis as an adverse event of immune checkpoint blockade for cancer therapy. Semin Arthritis Rheum (epub ahead of print)

  119. Abozaid HSM, Imam HMK, Abdelaziz MM et al (2017) High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis. Semin Arthritis Rheum 47:403–408

    Article  PubMed  Google Scholar 

  120. Siddhanamatha HR, Heung E, Lopez-Olivo MLA et al (2017) Quality assessment of websites providing educational content for patients with rheumatoid arthritis. Semin Arthritis Rheum 46:715–723

    Article  PubMed  Google Scholar 

  121. Elsaman AM, Radwan AR, Akmatov MK et al (2013) Amyloid arthropathy associated with multiple myeloma: a systematic analysis of 101 reported cases. Semin Arthritis Rheum 43:405–412

    Article  CAS  PubMed  Google Scholar 

  122. Ferreira JF, Ahmed Mohamed AA, Emery P (2016) Glucocorticoids and rheumatoid arthritis. Rheum Dis Clin N Am 42:33–46

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Mohamed N. Salem (Assistant Professor of Internal Medicine and Rheumatology Beni-Sueif University and General Secretary of the Egyptian Society of Rheumatology and Clinical Immunology), Dr. Nevin Hammam (Lecturer of Rheumatology, Assuit University and Consultant at University of Alberta, Canada) and Dr. Mohamed H. Abu-Zaid (Lecturer of Rheumatology, Tanta University) for their valuable inputs and revision of the review. Acknowledgement cordially extends to Professor Armen Y. Gasparyan in helping enhance the scientific writing of a biomedical review.

Funding

No source of funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tamer A. Gheita.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical statement

This article does not include any human participants and/or animals.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gheita, T.A., Eesa, N.N. Rheumatology in Egypt: back to the future. Rheumatol Int 39, 1–12 (2019). https://doi.org/10.1007/s00296-018-4192-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-018-4192-0

Keywords

Navigation